Process Development

Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News | Process Development

Catalent to Acquire RheinCell Therapeutics

Strengthens path towards industrialization of induced pluripotent stem cell-based therapies.

06.25.21

Portonbio Enters CAR-T Partnership with KAEDI

CDMO will provide KAEDI with CMC services for multiple projects.

Tim Wright, Editor, Contract Pharma 06.07.21

APIs | Cytotoxics and High Potency Manufacturing | Formulation Development | Process Development

Solubility Enhancement of Hydrophobic Drugs and APIs Using Hot Melt Extrusion

Efficient processing and production technology for solid molecular dispersion, HME can provide sustained, modified and targeted drug delivery.

Ameya Deshpande, Formulation Scientist, Avomeen 05.25.21

Aseptic Processing | Fill/Finish | Parenterals | Process Development | Scale-up/Technology Transfer

Vetter Commercial Manufacturing

Vetter’s decades of experience as a contract manufacturer providing fill & finish for injectable drugs helps deliver results for both large and small companies.

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Process Development

ProBioGen, Nobelpharma Enter Mfg. Agreement for Vax Project

To leverage ProBioGen’s vaccine development platform consisting of its AGE1.CR.pIX suspension cell line and its high performance cell culture medium.

Kristin Brooks 03.24.21

WuXi Biologics to Acquire CMAB Biopharma Group

Will increase 7000L drug substance capacity (MFG21) and drug product capacity (DP11) for liquid and lyophilization within its global manufacturing network.

Kristin Brooks 03.18.21

cGMP Manufacture | Process Development | Scale-up/Technology Transfer

Process Intensification: Understanding the Optimal Way to Maximize Productivity

Overcoming challenges of implementation and achieving increased volume, reduced timelines, decreased footprint, lower cost of goods, and increased flexibility.

Priyanka Gupta, Head of Market Entry Strategy for Protein Based Therapeutics, Sartorius 03.09.21

cGMP Manufacture | Drug Development | Process Development | R&D

Importance of Green Chemistry in Drug Development And Manufacturing

Learn how one CDMO is at the forefront of green chemistry, applying its principles to reduce the environmental and human impact of pharmaceutical production.

Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Industry News | Process Development

Capricor, Lonza Enter CAP-1002 Development Agreement

Lonza will perform process development activities for late-clinical and commercial-scale GMP manufacturing of CAP-1002.

Contract Pharma Staff 01.12.21

Breaking News | Industry News | Process Development

Sartorius to Acquire Novasep's Chromatography Biz

Novasep's division expects to generate sales of approximately €37 million in 2020 with double-digit profit margins.

Contract Pharma Staff 01.06.21

CHA Biotech Launches Global CDMO Biz

Matica Biotechnology to construct GMP facility for viral vector production in Texas.

Contract Pharma Staff 12.16.20

Emergent BioSolutions

Emergent BioSolutions provides contract manufacturing services for bulk drug substances and sterile injectable drug products.

Syed T. Husain, SVP & Head of CDMO Business Unit 12.01.20

Capsules | Formulation Development | Methods Development | Process Development | Validation

Corealis Pharma

...

Yves Roy, President 12.01.20

Chemistry | Drug Development | Formulation Development | Process Development

Dalton Pharma Services

...

Sneha Subrahmanyam, Marketing Specialist 11.17.20

Bioanalytical Services | Bioassay Development | Biologics, Proteins, Vaccines | Process Development | Process Validation

eBook: Increase Time to Market with Precision Dispensing Technology

Discover how to make safe, productive, efficient bioprocessing a reality by exploring the benefits of precision dispensing technology.

Sponsored released by Roquette 10.30.20

ProBioGen, Heidelberg Pharma Ink ATAC Agreement

ProBioGen is conducting cell line development, process development and GMP manufacturing of the mAb intermediates of Heidelberg’s ATAC molecules for cancer.

10.22.20